Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate to Severe Plaque Psoriasis: A Machine Learning Predictive Model

Description

Article full text The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.

Date made available	18 May 2021
Publisher	Adis Journals

DOI
10.6084/m9.figshare.14541864.v1

1 Article

Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model
Papp, K. A., Soliman, A. M., Done, N., Carley, C., Lemus Wirtz, E. & Puig, L., 21 May 2021, In: Dermatology and Therapy. 11, 4, p. 1291-1304 14 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
2 Citations (Scopus)

Cite this

Papp, K. A. (Creator), Soliman, A. M. (Creator), Done, N. (Creator), Carley, C. (Creator), Lemus Wirtz, E. (Contributor), Puig, L. (Creator) (18 May 2021). Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate to Severe Plaque Psoriasis: A Machine Learning Predictive Model. Adis Journals. 10.6084/m9.figshare.14541864.v1